Employees Retirement System of Texas purchased a new stake in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 200,000 shares of the real estate investment trust's stock, valued at approximately $3,390,000. Employees Retirement System of Texas owned about 0.06% of Healthcare Realty Trust as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently bought and sold shares of the business. Smartleaf Asset Management LLC raised its position in shares of Healthcare Realty Trust by 59.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 612 shares in the last quarter. Blue Trust Inc. increased its stake in shares of Healthcare Realty Trust by 130.3% in the fourth quarter. Blue Trust Inc. now owns 1,635 shares of the real estate investment trust's stock worth $30,000 after buying an additional 925 shares during the last quarter. Synergy Investment Management LLC acquired a new stake in Healthcare Realty Trust in the fourth quarter valued at $36,000. Lazard Asset Management LLC acquired a new stake in Healthcare Realty Trust in the fourth quarter valued at $45,000. Finally, Jones Financial Companies Lllp boosted its stake in Healthcare Realty Trust by 68.7% during the 4th quarter. Jones Financial Companies Lllp now owns 3,067 shares of the real estate investment trust's stock valued at $52,000 after acquiring an additional 1,249 shares during the last quarter.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on HR shares. Scotiabank dropped their target price on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a "sector perform" rating for the company in a research report on Tuesday, February 25th. Wedbush cut their price objective on Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating on the stock in a research note on Monday, May 5th. Wall Street Zen lowered Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research report on Saturday. Finally, Wells Fargo & Company reduced their price objective on Healthcare Realty Trust from $17.00 to $16.00 and set an "underweight" rating on the stock in a research note on Monday, March 10th. Two equities research analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $17.00.
Check Out Our Latest Stock Report on HR
Healthcare Realty Trust Stock Down 0.3%
Shares of NYSE:HR traded down $0.04 during trading on Friday, hitting $14.50. 3,406,467 shares of the company traded hands, compared to its average volume of 3,159,779. The business's fifty day moving average is $15.44 and its 200-day moving average is $16.43. The stock has a market capitalization of $5.10 billion, a price-to-earnings ratio of -8.15 and a beta of 0.92. Healthcare Realty Trust Incorporated has a one year low of $14.25 and a one year high of $18.90.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last issued its earnings results on Thursday, May 1st. The real estate investment trust reported $0.39 earnings per share for the quarter, hitting the consensus estimate of $0.39. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. The firm had revenue of $288.86 million for the quarter, compared to analyst estimates of $297.39 million. During the same period last year, the company earned $0.39 earnings per share. The firm's revenue for the quarter was down 9.2% on a year-over-year basis. On average, analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current year.
Healthcare Realty Trust Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, May 23rd. Shareholders of record on Monday, May 12th were given a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 8.55%. The ex-dividend date was Monday, May 12th. Healthcare Realty Trust's dividend payout ratio (DPR) is -113.76%.
Insiders Place Their Bets
In other Healthcare Realty Trust news, Director Thomas N. Bohjalian purchased 2,500 shares of the stock in a transaction dated Tuesday, May 13th. The shares were bought at an average cost of $14.71 per share, with a total value of $36,775.00. Following the completion of the acquisition, the director now owns 56,502 shares of the company's stock, valued at approximately $831,144.42. This trade represents a 4.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.37% of the stock is owned by insiders.
Healthcare Realty Trust Profile
(
Free Report)
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Read More

Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.